1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

28 Sep 2020
Admin
News Article

Hetero Launches Patient Compliant Pack Of Favivir 800/200 For COVID-19 Treatment

Hetero, one of India’s leading generic pharmaceutical companies and the world’s largest producer of antiretroviral drugs, announces the launch of first-ever ‘Patient Compliant Pack’ of Favivir 800/200 for the treatment of mild-to-moderate symptomatic COVID-19 patients in India.Favivir 800/200 will be available in a patient-friendly pack containing 16 tablets of favipiravir 800mg & 2 tablets of favipiravir 200mg, which is priced at Rs. 2,640/-.The higher strength of favipiravir 800 mg from Hetero has been approved by the Drug Controller General of India (DCGI). The product will be marketed and distributed by Hetero Healthcare Limited.The launch of ‘Favivir 800/200’ is aimed at enhancing patients’ adherence to treatment regimen by reducing the number of pills they are required to consume per day. The initial regimen of favipiravir 200mg requires patients to consume a total of 122 tablets for the 14-day treatment course.However, with the new Favivir 800/200 pack, the pill intake number is reduced to 32 tablets, effectively cutting down the pill burden by nearly 75%, leading to better treatment outcomes.Favivir is the second drug developed by Hetero after Covifor (remdesivir) used in the treatment of Covid-19. It is an oral antiviral medication that has shown positive clinical outcomes. The product will be made available at all retail medical outlets and hospital pharmacies across the country and sold only on prescription.Favivir has been the most prescribed brand in the market, as per IPM July 2020.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!